{"name":"Nexus Medical Partners","permalink":"nexus-medical-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/nexus-medical-partners","homepage_url":"http://www.nexusmp.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"617-472-2805","description":"","email_address":"contact@nexusmp.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Fri Jul 24 08:51:46 UTC 2009","updated_at":"Fri Jul 24 08:54:49 UTC 2009","overview":"<p>The Nexus Group is a private equity firm managing several funds with offices in Massachusetts and South Carolina and affiliates in San Francisco, London, Munich, Geneva and Tokyo. The Group specializes in making private equity investments and in providing strategic assistance to medical technology and life science companies globally.</p>","image":{"available_sizes":[[[150,70],"assets/images/resized/0005/4129/54129v1-max-150x150.jpg"],[[167,79],"assets/images/resized/0005/4129/54129v1-max-250x250.jpg"],[[167,79],"assets/images/resized/0005/4129/54129v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"400 Crown Colony Drive, Suite 104","address2":"","zip_code":" 02169","city":"Quincy","state_code":"MA","country_code":"USA","latitude":42.231436,"longitude":-71.014292}],"relationships":[{"is_past":false,"title":"Co-founder","person":{"first_name":"Edwin","last_name":"Snape","permalink":"edwin-snape","image":null}},{"is_past":false,"title":"Co-founder","person":{"first_name":"John","last_name":"F. Rousseau","permalink":"john-f-rousseau","image":null}}],"investments":[{"funding_round":{"round_code":"b","source_url":"http://www.presidiopharma.com/docs/Presidio_26M_Series_B.pdf","source_description":"Presidio Pharmaceuticals Closes $26 Million Series B Financing","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":8,"funded_day":29,"company":{"name":"Presidio Pharmaceuticals","permalink":"presidio","image":{"available_sizes":[[[150,67],"assets/images/resized/0005/4126/54126v2-max-150x150.jpg"],[[211,95],"assets/images/resized/0005/4126/54126v2-max-250x250.jpg"],[[211,95],"assets/images/resized/0005/4126/54126v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.cequentpharma.com/NovartisRelease.pdf","source_description":"Cequent Pharmaceuticals","raised_amount":9000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":18,"company":{"name":"Cequent Pharmaceuticals","permalink":"cequent-pharmaceuticals","image":{"available_sizes":[[[150,41],"assets/images/resized/0006/6015/66015v1-max-150x150.png"],[[250,69],"assets/images/resized/0006/6015/66015v1-max-250x250.png"],[[299,83],"assets/images/resized/0006/6015/66015v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.eyegatepharma.com/pdf/news/EyeGate%20Pharma%20_%20Series_C_PR_Final%203.12.08.pdf","source_description":"EYEGATE PHARMA SECURES $15M IN SERIES C VENTURE FUNDING","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":3,"funded_day":12,"company":{"name":"EyeGate Pharmaceuticals","permalink":"eyegate-pharmaceuticals","image":{"available_sizes":[[[150,76],"assets/images/resized/0007/0438/70438v1-max-150x150.jpg"],[[175,89],"assets/images/resized/0007/0438/70438v1-max-250x250.jpg"],[[175,89],"assets/images/resized/0007/0438/70438v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.neurotechusa.com/news_events/pr_2006-11-16.asp","source_description":"Neurotechâ„¢, Inc. Completes $35 Million Private Equity Financing","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":16,"company":{"name":"Neurotech","permalink":"neurotech","image":{"available_sizes":[[[150,47],"assets/images/resized/0008/4292/84292v1-max-150x150.jpg"],[[225,71],"assets/images/resized/0008/4292/84292v1-max-250x250.jpg"],[[225,71],"assets/images/resized/0008/4292/84292v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/03/myoscience-closes-33m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Myoscience Closes $33M Series D Financing","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":21,"company":{"name":"MyoScience","permalink":"myoscience","image":{"available_sizes":[[[150,76],"assets/images/resized/0010/9093/109093v1-max-150x150.jpg"],[[213,109],"assets/images/resized/0010/9093/109093v1-max-250x250.jpg"],[[213,109],"assets/images/resized/0010/9093/109093v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/05/kiyatec-raises-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"KIYATEC Raises Series A Funding","raised_amount":null,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":23,"company":{"name":"KIYATEC","permalink":"kiyatec","image":{"available_sizes":[[[150,32],"assets/images/resized/0019/1364/191364v1-max-150x150.jpg"],[[250,54],"assets/images/resized/0019/1364/191364v1-max-250x250.jpg"],[[450,98],"assets/images/resized/0019/1364/191364v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}